The defendents, North China Pharmaceuticals and Hebei Wellcome Pharmaceutical Co. were sentenced to 153 million USD fine for creating a monopoly but indicated that they will prepare an appeal.

China Bio news release, December 6, 2013

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny